Dr. Yu-Jui Yvonne Wan's lab at UC Davis focuses on creating and testing a novel nanodrug aimed at improving metabolic health and preventing related cancers like liver and colorectal cancer. The lab studies how changes in gut bacteria affect the development of metabolic diseases and aims to design drugs that can effectively target these alterations. Their innovative approaches include developing compounds that can deliver specific biological signals to help combat conditions like insulin resistance and fatty liver disease.

The lab led by Prof. Oliver Fiehn at UC Davis focuses on enhancing the field of metabolomics, which studies the unique chemical fingerprints that cellular processes leave behind. One of their main projects aims to create a cloud-based database called LC-BinBase that standardizes the analysis of metabolomics and lipidomics data, enabling better reproducibility across different laboratories and instruments. By developing advanced algorithms and offering workshops for collaboration, the lab is striving to improve the quality and usability of metabolic data for biomedical researchers.

Dr. Blake C. Meyers' lab at UC Davis focuses on understanding small RNAs in plant reproduction, particularly in maize. The research explores how specific classes of small RNAs contribute to the development of male reproductive organs and their roles in male fertility. By using advanced imaging and genetic techniques, the lab aims to uncover the production, localization, and functions of these critical molecules in plants.

Dr. Donald Bers' lab at UC Davis focuses on understanding the critical molecular mechanisms that lead to heart failure and arrhythmias, which are significant health issues worldwide. They investigate the role of proteins like the cardiac ryanodine receptor and CaMKII, using advanced techniques to explore how these proteins function under normal and pathological conditions. The ultimate goal is to develop new therapeutic strategies targeting these molecular mechanisms to improve heart health.

Dr. Stefano Morotti's lab focuses on understanding heart failure with preserved ejection fraction (HFpEF), a condition affecting many, particularly women. The lab combines experimental and computational techniques to investigate how the disease varies among patients and to identify potential new treatments. By studying the cellular mechanisms behind HFpEF, they aim to develop more effective therapies tailored to different patient profiles.

Professor Manuel F. Navedo's lab at UC Davis focuses on understanding the mechanisms behind vascular smooth muscle dysfunction related to diabetes and heart failure. The research particularly investigates how pressure influences calcium channels in blood vessels and how this process can affect blood flow and blood pressure in health and disease. By exploring these mechanisms, the lab aims to identify new potential treatments for vascular complications associated with lifestyle-related diseases.

Dr. Arta Monir Monjazeb's lab at UC Davis focuses on understanding how obesity affects cancer treatment, specifically how it influences the effectiveness of radiotherapy. They study the mechanisms behind why obese cancer patients respond poorly to treatment, utilizing various mouse models to explore how obesity-related factors like the hormone leptin can alter cancer cell behavior and the immune response. By identifying these links, the lab aims to develop improved treatment strategies for obese cancer patients and contribute to personalized medicine.

Dr. Negar Omidvari's lab at UC Davis focuses on understanding long-term health problems that some COVID-19 survivors face. They are using advanced imaging techniques to study how the immune system is affected by these lingering symptoms. By exploring the connections between immune responses, imaging data, and patient experiences, the lab aims to improve our understanding of these complex issues and help develop better treatments.

Dr. Siqi Li's lab focuses on improving imaging techniques for diagnosing and monitoring pediatric cancers using advanced PET technology. They aim to develop methods that allow for quicker, accurate quantification of disease progression, making imaging safer and more effective for children. By utilizing innovative imaging techniques, the lab strives to enhance clinical outcomes for young cancer patients.

Dr. Jeroen Saeij's lab at UC Davis focuses on understanding how the Toxoplasma gondii parasite survives and grows in human cells, particularly in individuals with weakened immune systems. The lab investigates how human immune responses, including certain cytokines like interferon and tumor necrosis factor, can inhibit Toxoplasma growth, and how the parasite counters these defenses. Through advanced techniques like CRISPR screens, the research aims to identify potential new treatments for toxoplasmosis and to better predict which Toxoplasma strains may be more virulent in humans.

Dr. Luis F. Santana's lab focuses on understanding how the heart’s natural pacemakers function and are influenced by their blood supply and metabolic activity. They explore how the cells in the sino-atrial node generate electrical signals to control heartbeats, especially during heart failure. The lab combines experimental techniques and computer models to uncover the complexities of cardiac excitability and rhythm regulation, aiming to develop new treatment strategies for heart rhythm disorders.

Dr. Boryana Stamova's research lab focuses on understanding how changes in gene expression in blood can help predict recovery outcomes after an ischemic stroke. By studying RNA from patients shortly after a stroke, the lab aims to uncover new biomarkers that are more effective than traditional clinical measures. This research could lead to better patient treatment options and personalized approaches to stroke recovery.

Dr. Cheemeng Tan's lab at UC Davis focuses on studying extracellular vesicles (EVs), which are tiny particles that cells release to communicate with each other. By using synthetic biology techniques, the lab aims to create new EV mimetics that can be used as drug delivery systems. This research could help refine the therapeutic use of EVs and make them more effective for treating diseases by enhancing their production and consistency.

Dr. Neil Hunter's lab at UC Davis explores the critical role of the BRCA2 protein in the process of meiosis, which is how sperm and eggs are formed. The research focuses on understanding how BRCA2 functions in ensuring accurate chromosome segregation and maintaining gamete quality. His lab combines advanced genetic, genomic, and biochemical techniques to uncover the mechanisms of BRCA2 during reproductive cell division, with implications for addressing infertility and genetic disorders.

Megan Y Dennis's lab at UC Davis focuses on understanding how human gene duplications influence neurodevelopment and are linked to various neurological disorders. Their research employs innovative techniques like CRISPR and utilizes zebrafish as a model organism to study the effects of duplicated genes on brain development. Additionally, the lab is developing improved computational approaches to identify genetic variants associated with neurodevelopmental disorders, particularly in complex regions of the human genome.

Dr. Satya Dandekar’s research focuses on eliminating HIV using innovative strategies that involve mesenchymal stem cells (MSC) in a monkey model. The lab investigates how these stem cells can enhance the immune system's ability to target and eradicate the virus. This work is crucial for developing new treatments and vaccines against HIV and understanding severe immune responses.

Dr. Yuanpei Li's lab focuses on developing innovative nanotherapeutics designed to improve treatment for brain cancers, particularly aggressive pediatric tumors like diffuse midline glioma (DMG) and high-grade gliomas in dogs. Through advanced nanoparticle technology, they aim to enhance drug delivery across the challenging blood-brain barrier and overcome resistance to current therapies. By studying both human and canine models, the lab works to create effective treatments that could significantly improve patient outcomes.

Dr. Xinbin Chen's lab at UC Davis focuses on developing new treatments for triple negative breast cancer by targeting a mutated form of the p53 protein, which is involved in many cancers. The lab studies how certain proteins interact to promote the expression of this mutant p53 and explores how blocking these interactions can inhibit tumor growth. They are also investigating whether a small molecule can enhance the effectiveness of chemotherapy in cancers reliant on mutant p53.

Dr. Richard M. Levenson's lab at UC Davis focuses on improving breast cancer diagnostics, particularly in low and middle-income countries like Ghana. By combining advanced technologies such as millifluidics and digital imaging, the lab aims to create cost-effective, automated instruments that can provide high-quality diagnostic images from breast cancer biopsies. This project not only aims to enhance diagnostic capabilities but also seeks to integrate real-time therapy guidance and AI tools to better support local healthcare providers.

Dr. David E. Olson's lab focuses on discovering new treatments for addiction by developing non-hallucinogenic compounds that can promote changes in brain structure and function. These compounds, known as psychoplastogens, could offer therapeutic benefits for conditions like substance use disorders without the side effects of hallucinations. The lab employs innovative techniques to rapidly identify and evaluate these promising molecules.